169 related articles for article (PubMed ID: 7779712)
1. Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.
Laws AL; Matthew AM; Double JA; Bibby MC
Br J Cancer; 1995 Jun; 71(6):1204-9. PubMed ID: 7779712
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
Thomsen LL; Baguley BC; Wilson WR
Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
[TBL] [Abstract][Full Text] [Related]
3. Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid.
Ching LM; Xu ZF; Gummer BH; Palmer BD; Joseph WR; Baguley BC
Br J Cancer; 1995 Aug; 72(2):339-43. PubMed ID: 7640215
[TBL] [Abstract][Full Text] [Related]
4. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
Ching LM; Joseph WR; Crosier KE; Baguley BC
Cancer Res; 1994 Feb; 54(4):870-2. PubMed ID: 8313372
[TBL] [Abstract][Full Text] [Related]
5. The effect of 5,6-dimethylxanthenone-4-acetic acid on tumour necrosis factor production by human immune cells.
Patel S; Parkin SM; Bibby MC
Anticancer Res; 1997; 17(1A):141-50. PubMed ID: 9066644
[TBL] [Abstract][Full Text] [Related]
6. Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
Baguley BC; Cole G; Thomsen LL; Li Z
Cancer Chemother Pharmacol; 1993; 33(1):77-81. PubMed ID: 8269593
[TBL] [Abstract][Full Text] [Related]
7. Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.
McKeage MJ; Kestell P; Denny WA; Baguley BC
Cancer Chemother Pharmacol; 1991; 28(6):409-13. PubMed ID: 1934244
[TBL] [Abstract][Full Text] [Related]
8. In vitro methods for screening agents with an indirect mechanism of antitumour activity: xanthenone analogues of flavone acetic acid.
Ching LM; Finlay GJ; Joseph WR; Baguley BC
Eur J Cancer; 1991; 27(12):1684-9. PubMed ID: 1782083
[TBL] [Abstract][Full Text] [Related]
9. Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice.
Ching LM; Joseph WR; Baguley BC
Br J Cancer; 1992 Jul; 66(1):128-30. PubMed ID: 1637661
[No Abstract] [Full Text] [Related]
10. The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice.
Zhao L; Ching LM; Kestell P; Baguley BC
Br J Cancer; 2002 Aug; 87(4):465-70. PubMed ID: 12177785
[TBL] [Abstract][Full Text] [Related]
11. Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid.
Ching LM; Cao Z; Kieda C; Zwain S; Jameson MB; Baguley BC
Br J Cancer; 2002 Jun; 86(12):1937-42. PubMed ID: 12085190
[TBL] [Abstract][Full Text] [Related]
12. Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.
Ching LM; Joseph WR; Zhuang L; Baguley BC
Cancer Chemother Pharmacol; 1994; 35(2):153-60. PubMed ID: 7987993
[TBL] [Abstract][Full Text] [Related]
13. Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: relationship between plasma nitrate elevation and the induction of tumour necrosis.
Veszelovszky E; Thomsen LL; Li Z; Baguley BC
Eur J Cancer; 1993; 29A(3):404-8. PubMed ID: 8398341
[TBL] [Abstract][Full Text] [Related]
14. Persistent induction of nitric oxide synthase in tumours from mice treated with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid.
Moilanen E; Thomsen LL; Miles DW; Happerfield DW; Knowles RG; Moncada S
Br J Cancer; 1998; 77(3):426-33. PubMed ID: 9472639
[TBL] [Abstract][Full Text] [Related]
15. Effect of tumour growth on the macrophage response to the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
Ching LM; Joseph WR; Baguley BC
Anticancer Res; 1993; 13(6A):2069-75. PubMed ID: 8297115
[TBL] [Abstract][Full Text] [Related]
16. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
Browne WL; Wilson WR; Baguley BC; Ching LM
Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
[TBL] [Abstract][Full Text] [Related]
17. Changes in coagulation and permeability properties of human endothelial cells in vitro induced by TNF-alpha or 5,6 MeXAA.
Watts ME; Arnold S; Chaplin DJ
Br J Cancer Suppl; 1996 Jul; 27():S164-7. PubMed ID: 8763872
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
Baguley BC; Zhuang L; Kestell P
Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
Bibby MC; Phillips RM; Double JA; Pratesi G
Br J Cancer; 1991 Jan; 63(1):57-62. PubMed ID: 1989665
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Woon ST; Zwain S; Schooltink MA; Newth AL; Baguley BC; Ching LM
Eur J Cancer; 2003 May; 39(8):1176-83. PubMed ID: 12736120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
